Loading...

BioGaia AB (publ)

BIOGYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$9.75
$0.00(0.00%)

BioGaia AB (publ) (BIOGY) Stock Overview

Explore BioGaia AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.2/100

Key Financials

Market Cap986M
P/E Ratio30.81
EPS (TTM)$0.29
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Week$8.14
1 Month$8.55
3 Months$10.08
1 Year Target$11.69

BIOGY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioGaia AB (publ) (BIOGY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.69.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.81 and a market capitalization of 986M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;